Zum Inhalt springen

Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS

@spjuraschek.bsky.social did:plc:hduofm275xjwl65blurpayye

Internist, hypertension specialist, epidemiologist, and trialist interest in healthy food access, sodium, heart disease, blood pressure regulation, and gout

Bei Bluesky seit

Follower
954
Folgt
443
Posts
481
Tage in Ranglisten
0

Zusammenfassung

Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS (@spjuraschek.bsky.social) ist seit 14 November 2024 auf Bluesky. Das Konto hat 954 Follower, folgt 443 Konten und hat 481 Posts veröffentlicht.

Ranglisten-Platzierungen

Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.

Dieses Konto war noch in keiner Tagesrangliste.

Zuletzt gelikte Posts

Öffentliche Likes aus dem Bluesky-Netzwerk.

  • American Journal of Hypertension@amjhypertension.bsky.social

    #HotOffThePress Effects of Anti-Hypertensive Agents on Orthostatic Changes: Secondary Analysis of the Treatment of Mild Hypertension Study (TOMHS) academic.oup.com/ajh/advance-...

    Post anzeigen
  • Marwah Abdalla, MD MPH@marwahabdalla.bsky.social

    We have more ways to measure blood pressure than ever before but not necessarily more confidence in what those measurements mean. Our NHLBI workshop report in @jaccjournals.bsky.social chaired w/ @spjuraschek.bsky.social provides an implementation roadmap. www.sciencedirect.com/science/arti...

    Post anzeigen
  • Andrew Michael South, MD, MS@asouth-neph.bsky.social

    Terrific to learn from and work with you @spjuraschek.bsky.social and so many of the fantastic #Hypertension folks out there #BloodPressure #LifeSpan www.sciencedirect.com/science/arti...

    Post anzeigen
  • Alex Chang, MD@alexchangmd.bsky.social

    Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/

    Post anzeigen
  • Iain Bressendorff, MD PhD@ibressendorff.bsky.social

    Huge fan of spiro, but wouldn’t use it first-line if I didn’t suspect hyperaldosteronism. No CVD outcome data and the side effects for men are not trivial. Don’t feel that the modest effect on BP in primary HTN justifies its use over A/C/D.

    Post anzeigen

Melde dich an, um mehr zu sehen

Blockierte Konten

Blockierungen sind auf Bluesky öffentlich.

Dieses Konto blockiert niemanden.